Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metabolic and cardiovascular risk markers in transgender men starting testosterone
RBR-8xtsgvvNot yet recruiting
- Sponsor
- Federal University of São Paulo
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of testosterone in gender dysphoria (GD), sponsored by Federal University of São Paulo. Planned start Dec 2024; status: not yet recruiting.
02
Drugs
testosterone
03
Conditions
gender dysphoria (GD)
Beyond the preview
Go deeper on RBR-8xtsgvv.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-8xtsgvv.